Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Insurance Considerations for the Pharmacy Professional

Author(s):  Jones Kirsten

Issue:  May/Jun 2021 - Volume 25, Number 3
View All Articles in Issue

Page(s):  190-195

Insurance Considerations for the Pharmacy Professional Page 1
Insurance Considerations for the Pharmacy Professional Page 2
Insurance Considerations for the Pharmacy Professional Page 3
Insurance Considerations for the Pharmacy Professional Page 4
Insurance Considerations for the Pharmacy Professional Page 5
Insurance Considerations for the Pharmacy Professional Page 6

Download in electronic PDF format for $75

Abstract:  Risk, which can come from various sources, is the exposure to loss or injury. Included, but not limited to common risks associated by business owners, are natural disasters, accidents, legal liabilities, weather-related events, and criminal activities. Specific to pharmacy is professional liability risk, including physical harm to a patient. This article provides an understanding of some of the risks faced by business owners and pharmacists, transferal of risk to another entity such as an insurance company, and an understanding of the insurance policy itself.

Related Keywords: Kristen Jones, PharmD, risk, natural disasters, accidents, legal liability, professional liability, insurance policies, insuring agreements, definitions, endorsements, exclusions, employment practice liability, risk management, disaster recovery, case studies

Related Categories: BUSINESS, CASE REPORTS, PROFESSIONAL ISSUES, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Insurance Considerations for the Pharmacy Professional
Jones Kirsten
May/Jun 2021
Pg. 190-195

Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where
Baker Kenneth R
Nov/Dec 2008
Pg. 514-523

Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered?
Baker Kenneth R
Sep/Oct 2008
Pg. 420-424

Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover
Rizo Mike
Jul/Aug 2013
Pg. 290-293

Considerations for Pharmacists Working in Major Disaster Areas
Kawataba Yoshinori
Nov/Dec 2013
Pg. 459-463

Natural Tragedies: Planning for Disasters and Emergencies
Williams LaVonn A
Sep/Oct 2011
Pg. 368-371

Legal & Ethical Issues for Pharmacy Websites
King LD
, Brashares Jennifer
Mar/Apr 2003
Pg. 88-92

Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Thomson Cassandra Marie
, Savji Taslim
Nov/Dec 2014
Pg. 456-460

Profile of a Practice: Custom Rx Compounding and Natural Pharmacy
Allen Loyd V Jr
Mar/Apr 2001
Pg. 118-119

Legal Issues: Technicians in the Compounding Pharmacy Practice
Fix Jennifer Taylor
Jul/Aug 2002
Pg. 274-275

Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional
Pournadeali Kasra
Nov/Dec 1999
Pg. 428-433

PreScription: State or Federal Control of Pharmacy Practice
Allen Loyd V Jr
May/Jun 2007
Pg. 178

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996
Allen Loyd V Jr
Jan/Feb 2008
Pg. 63

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

PostScription: Pharmacy, Pharmacists, and Pharmacy Practice
Allen Loyd V Jr
Jan/Feb 2005
Pg. 88

Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
Jul/Aug 2020
Pg. 287-295

Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal
, Levesque Dan, Frye John, Rashid Mamoon
Jul/Aug 2020
Pg. 322-326

PostScription: Regulatory Uncertainty Requires Professional Responsibility
King LD
Jan/Feb 2002
Pg. 80

Return to Top